Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

Sussman, TA; Li, H; Hobbs, B; Funchain, P; McCrae, KR; Khorana, AA

Khorana, AA (corresponding author), Cleveland Clin Fdn, Dept Hematol & Oncol, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021; 9 (1):

Abstract

Background Thromboembolism (TE) in cancer significantly contributes to morbidity and mortality. Little is known about the incidence of arterial TE (AT......

Full Text Link